Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Graham A. Showell is active.

Publication


Featured researches published by Graham A. Showell.


Bioorganic & Medicinal Chemistry | 1998

Binding of 2,4-disubstituted morpholines at human D4 dopamine receptors.

Graham A. Showell; Frances Emms; Rosemarie Marwood; Desmond O'Connor; Smita Patel; Paul D. Leeson

The synthesis of a series of 2,4-disubstituted morpholines is described and their affinities at human dopamine receptors reported. The orally bioavailable 7-azaindole compound 11 has nanomolar affinity at the hD4 receptor with > 1000-fold selectivity over the hD2 receptor.


Bioorganic & Medicinal Chemistry | 2015

Design and synthesis of 1,1-disubstituted-1-silacycloalkane-based compound libraries.

Raquel Ortega; Jorge Sanchez-Quesada; Christoph Lorenz; Grzegorg Dolega; Anna Karawajczyk; Miguel Sanz; Graham A. Showell; Fabrizio Giordanetto

The introduction of silicon in biologically-relevant molecules represents an interesting medicinal chemistry tactic. Its use is mainly confined to the fine-tuning of specific molecular properties and organosilicon compounds are underrepresented in typical screening libraries. As part of the European Lead Factory efforts to generate novel, drug discovery-relevant chemical matter, the design and synthesis of 1,1-disubstituted-1-silacycloalkane-based compound libraries is described.


Journal of The Chemical Society, Chemical Communications | 1988

Ester bio-isosteres: synthesis of oxadiazolyl-1-azabicyclo[2.2.1]heptanes as muscarinic agonists

John Saunders; Angus Murray Macleod; Kevin John Merchant; Graham A. Showell; Roger J. Snow; Leslie J. Street; Raymond Baker

The methyl ester functionality in arecoline and related esters has been replaced by 1,2,4-oxadiazole to generate the most potent and efficacious muscarinic agonists known.


Journal of The Chemical Society, Chemical Communications | 1992

Synthesis, physicochemical and conformational properties of (3R,4R)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane, a novel M1 selective muscarinic partial agonist

Raymond Baker; Graham A. Showell; Leslie J. Street; John Saunders; Karst Hoogsteen; Stephen Freedman; Richard Hargreaves

The cyclopropyloxadiazole derivative described in the title has been shown to be a functionally selective M1 partial agonist with antagonist properties in M2 and M3 muscarinic receptor assays; conformational studies indicate free rotation around the oxadiazole–azanorbornane bond, whilst X-ray studies reveal that the cyclopropyl group is in conjugation with the oxadiazole CN bond.


Journal of Medicinal Chemistry | 1990

Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors

Leslie Joseph Harlow Street; Baker R; Tracey Book; Clare O. Kneen; Angus Murray Macleod; Kevin John Merchant; Graham A. Showell; John Saunders; Richard H. Herbert


Journal of Medicinal Chemistry | 1983

Synthesis and antihypertensive activity of 6,7-disubstituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols.

John Morris Evans; Charles S. Fake; Thomas C. Hamilton; Robert H. Poyser; Graham A. Showell


Journal of Medicinal Chemistry | 1994

High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group

Graham A. Showell; Sylvie Bourrain; Joseph George Neduvelil; Stephen Robert Fletcher; Raymond Baker; Alan P. Watt; Alan E. Fletcher; Stephen Freedman; John A. Kemp


Journal of Medicinal Chemistry | 1991

Tetrahydropyridyloxadiazoles : semirigid muscarinic ligands

Graham A. Showell; Tracey L. Gibbons; Clare O. Kneen; Angus Murray Macleod; Kevin John Merchant; John Saunders; Stephen B. Freedman; Shailendra Patel; Baker R


Journal of Medicinal Chemistry | 1988

Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart

Paul D. Leeson; David Ellis; John Colin Emmett; Virendra P. Shah; Graham A. Showell; Anthony H. Underwood


Journal of Medicinal Chemistry | 1989

Selective thyromimetics: cardiac-sparing thyroid hormone analogues containing 3'-arylmethyl substituents

Paul D. Leeson; John Colin Emmett; Virendra P. Shah; Graham A. Showell; Ricardo Novelli; H. Douglas Prain; Martin G. Benson; David Ellis; Nigel J. Pearce; Anthony H. Underwood

Collaboration


Dive into the Graham A. Showell's collaboration.

Researchain Logo
Decentralizing Knowledge